Evidence map›Paper›PMID 39539624›Full record

ArticleFrontiers in pharmacology2024

Antidiabetic potential of

Amal Elrherabi, Rhizlan Abdnim, El Hassania Loukili, Abdelouahid Laftouhi, Fatima Zahra Lafdil, Mohamed Bouhrim, Ramzi A Mothana, Omar M Noman, Bruno Eto, Abderrahim Ziyyat and 3 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Metabolite Profiling of Lavender (Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Therapeutic Potential ofFood science & nutrition · 2025
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amal ElrherabiLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.
Rhizlan AbdnimLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.
El Hassania LoukiliEuromed University of Fes, UEMF, Fes, Morocco.
Abdelouahid LaftouhiLaboratory of Electrochemistry, Modeling and Environment Engineering (LIEME), Sidi Mohamed Ben Abdellah University, Faculty of Sciences Fes, Fes, Morocco.
Fatima Zahra LafdilLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.
Mohamed BouhrimBiological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco.
Ramzi A MothanaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Omar M NomanDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Bruno EtoLaboratories TBC, Laboratory of Pharmacology, Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Lille, Lille, France.
Abderrahim ZiyyatLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.
Hassane MekhfiLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.
Abdelkhaleq LegssyerLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.
Mohamed BnouhamLaboratory of Bioresources, Biotechnology, Ethnopharmacology, and Health, Faculty of Sciences Mohammed First University, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the increasing global prevalence of type 2 diabetes (T2D) and obesity, there is a pressing need for novel therapeutic interventions. Methods: The pharmacological potential of Results: The extract demonstrated concentration-dependent inhibition of pancreatic lipase (IC Conclusion: These findings highlight the multifaceted pharmacological potential of

Indexed as

antiinflammatoryantioxidantglycationLavandula stoechaspancreatic lipasetype 2 diabetes

Identifiers

PMID39539624
PMCPMC11557384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.